Hong Yuan Holding Group
Hong Yuan Holding Group (HGYN) Stock Competitors & Peer Comparison
See (HGYN) competitors and their performances in Stock Market.
Peer Comparison Table: Shell Companies Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| HGYN | $0.08 | -18.37% | 6M | N/A | N/A | N/A |
| QMIS | $0.25 | +0.00% | 30.5B | N/A | N/A | N/A |
| GSHN | $22.70 | +2.71% | 9.3B | -2270.00 | -$0.01 | N/A |
| KATX | $1.05 | +0.00% | 1.9B | N/A | N/A | N/A |
| CCYC | $11.25 | +0.00% | 1.7B | N/A | N/A | N/A |
| WCHS | $6.60 | +31.74% | 700.7M | N/A | N/A | N/A |
| WPCBF | $0.00 | +100.00% | 700.3M | N/A | N/A | N/A |
| NOTR | $13.00 | +0.00% | 570.9M | -433.33 | -$0.03 | N/A |
| FZRO | $2.00 | N/A | 346.2M | -0.00 | -$4,243,300.50 | N/A |
| RGLG | $1.13 | +11.88% | 342.8M | -0.11 | -$10.00 | N/A |
Stock Comparison
HGYN vs QMIS Comparison May 2026
HGYN plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HGYN stands at 6M. In comparison, QMIS has a market cap of 30.5B. Regarding current trading prices, HGYN is priced at $0.08, while QMIS trades at $0.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HGYN currently has a P/E ratio of N/A, whereas QMIS's P/E ratio is N/A. In terms of profitability, HGYN's ROE is -0.43%, compared to QMIS's ROE of N/A. Regarding short-term risk, HGYN is more volatile compared to QMIS. This indicates potentially higher risk in terms of short-term price fluctuations for HGYN.Check QMIS's competition here
HGYN vs GSHN Comparison May 2026
HGYN plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HGYN stands at 6M. In comparison, GSHN has a market cap of 9.3B. Regarding current trading prices, HGYN is priced at $0.08, while GSHN trades at $22.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HGYN currently has a P/E ratio of N/A, whereas GSHN's P/E ratio is -2270.00. In terms of profitability, HGYN's ROE is -0.43%, compared to GSHN's ROE of +0.07%. Regarding short-term risk, HGYN is more volatile compared to GSHN. This indicates potentially higher risk in terms of short-term price fluctuations for HGYN.Check GSHN's competition here
HGYN vs KATX Comparison May 2026
HGYN plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HGYN stands at 6M. In comparison, KATX has a market cap of 1.9B. Regarding current trading prices, HGYN is priced at $0.08, while KATX trades at $1.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HGYN currently has a P/E ratio of N/A, whereas KATX's P/E ratio is N/A. In terms of profitability, HGYN's ROE is -0.43%, compared to KATX's ROE of +2.21%. Regarding short-term risk, HGYN is less volatile compared to KATX. This indicates potentially lower risk in terms of short-term price fluctuations for HGYN.Check KATX's competition here
HGYN vs CCYC Comparison May 2026
HGYN plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HGYN stands at 6M. In comparison, CCYC has a market cap of 1.7B. Regarding current trading prices, HGYN is priced at $0.08, while CCYC trades at $11.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HGYN currently has a P/E ratio of N/A, whereas CCYC's P/E ratio is N/A. In terms of profitability, HGYN's ROE is -0.43%, compared to CCYC's ROE of +0.08%. Regarding short-term risk, HGYN is more volatile compared to CCYC. This indicates potentially higher risk in terms of short-term price fluctuations for HGYN.Check CCYC's competition here
HGYN vs WCHS Comparison May 2026
HGYN plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HGYN stands at 6M. In comparison, WCHS has a market cap of 700.7M. Regarding current trading prices, HGYN is priced at $0.08, while WCHS trades at $6.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HGYN currently has a P/E ratio of N/A, whereas WCHS's P/E ratio is N/A. In terms of profitability, HGYN's ROE is -0.43%, compared to WCHS's ROE of +1.70%. Regarding short-term risk, HGYN is more volatile compared to WCHS. This indicates potentially higher risk in terms of short-term price fluctuations for HGYN.Check WCHS's competition here
HGYN vs WPCBF Comparison May 2026
HGYN plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HGYN stands at 6M. In comparison, WPCBF has a market cap of 700.3M. Regarding current trading prices, HGYN is priced at $0.08, while WPCBF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HGYN currently has a P/E ratio of N/A, whereas WPCBF's P/E ratio is N/A. In terms of profitability, HGYN's ROE is -0.43%, compared to WPCBF's ROE of +0.00%. Regarding short-term risk, HGYN is more volatile compared to WPCBF. This indicates potentially higher risk in terms of short-term price fluctuations for HGYN.Check WPCBF's competition here
HGYN vs NOTR Comparison May 2026
HGYN plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HGYN stands at 6M. In comparison, NOTR has a market cap of 570.9M. Regarding current trading prices, HGYN is priced at $0.08, while NOTR trades at $13.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HGYN currently has a P/E ratio of N/A, whereas NOTR's P/E ratio is -433.33. In terms of profitability, HGYN's ROE is -0.43%, compared to NOTR's ROE of -0.01%. Regarding short-term risk, HGYN is less volatile compared to NOTR. This indicates potentially lower risk in terms of short-term price fluctuations for HGYN.Check NOTR's competition here
HGYN vs FZRO Comparison May 2026
HGYN plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HGYN stands at 6M. In comparison, FZRO has a market cap of 346.2M. Regarding current trading prices, HGYN is priced at $0.08, while FZRO trades at $2.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HGYN currently has a P/E ratio of N/A, whereas FZRO's P/E ratio is -0.00. In terms of profitability, HGYN's ROE is -0.43%, compared to FZRO's ROE of +0.00%. Regarding short-term risk, HGYN is more volatile compared to FZRO. This indicates potentially higher risk in terms of short-term price fluctuations for HGYN.Check FZRO's competition here
HGYN vs RGLG Comparison May 2026
HGYN plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HGYN stands at 6M. In comparison, RGLG has a market cap of 342.8M. Regarding current trading prices, HGYN is priced at $0.08, while RGLG trades at $1.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HGYN currently has a P/E ratio of N/A, whereas RGLG's P/E ratio is -0.11. In terms of profitability, HGYN's ROE is -0.43%, compared to RGLG's ROE of -1.03%. Regarding short-term risk, HGYN is less volatile compared to RGLG. This indicates potentially lower risk in terms of short-term price fluctuations for HGYN.Check RGLG's competition here
HGYN vs CINV Comparison May 2026
HGYN plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HGYN stands at 6M. In comparison, CINV has a market cap of 338.6M. Regarding current trading prices, HGYN is priced at $0.08, while CINV trades at $4.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HGYN currently has a P/E ratio of N/A, whereas CINV's P/E ratio is N/A. In terms of profitability, HGYN's ROE is -0.43%, compared to CINV's ROE of +0.59%. Regarding short-term risk, HGYN is more volatile compared to CINV. This indicates potentially higher risk in terms of short-term price fluctuations for HGYN.Check CINV's competition here
HGYN vs AGGI Comparison May 2026
HGYN plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HGYN stands at 6M. In comparison, AGGI has a market cap of 300.9M. Regarding current trading prices, HGYN is priced at $0.08, while AGGI trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HGYN currently has a P/E ratio of N/A, whereas AGGI's P/E ratio is 7.45. In terms of profitability, HGYN's ROE is -0.43%, compared to AGGI's ROE of +4.95%. Regarding short-term risk, HGYN is more volatile compared to AGGI. This indicates potentially higher risk in terms of short-term price fluctuations for HGYN.Check AGGI's competition here
HGYN vs AMRR Comparison May 2026
HGYN plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HGYN stands at 6M. In comparison, AMRR has a market cap of 250.6M. Regarding current trading prices, HGYN is priced at $0.08, while AMRR trades at $1.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HGYN currently has a P/E ratio of N/A, whereas AMRR's P/E ratio is N/A. In terms of profitability, HGYN's ROE is -0.43%, compared to AMRR's ROE of +0.70%. Regarding short-term risk, HGYN is more volatile compared to AMRR. This indicates potentially higher risk in terms of short-term price fluctuations for HGYN.Check AMRR's competition here
HGYN vs RENEF Comparison May 2026
HGYN plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HGYN stands at 6M. In comparison, RENEF has a market cap of 164.6M. Regarding current trading prices, HGYN is priced at $0.08, while RENEF trades at $12.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HGYN currently has a P/E ratio of N/A, whereas RENEF's P/E ratio is -74.47. In terms of profitability, HGYN's ROE is -0.43%, compared to RENEF's ROE of +0.84%. Regarding short-term risk, HGYN is more volatile compared to RENEF. This indicates potentially higher risk in terms of short-term price fluctuations for HGYN.Check RENEF's competition here
HGYN vs KAST Comparison May 2026
HGYN plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HGYN stands at 6M. In comparison, KAST has a market cap of 164.6M. Regarding current trading prices, HGYN is priced at $0.08, while KAST trades at $4.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HGYN currently has a P/E ratio of N/A, whereas KAST's P/E ratio is N/A. In terms of profitability, HGYN's ROE is -0.43%, compared to KAST's ROE of -0.25%. Regarding short-term risk, HGYN is less volatile compared to KAST. This indicates potentially lower risk in terms of short-term price fluctuations for HGYN.Check KAST's competition here
HGYN vs GWIN Comparison May 2026
HGYN plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HGYN stands at 6M. In comparison, GWIN has a market cap of 160.3M. Regarding current trading prices, HGYN is priced at $0.08, while GWIN trades at $0.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HGYN currently has a P/E ratio of N/A, whereas GWIN's P/E ratio is -1.00. In terms of profitability, HGYN's ROE is -0.43%, compared to GWIN's ROE of +0.00%. Regarding short-term risk, HGYN is more volatile compared to GWIN. This indicates potentially higher risk in terms of short-term price fluctuations for HGYN.Check GWIN's competition here
HGYN vs TGLO Comparison May 2026
HGYN plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HGYN stands at 6M. In comparison, TGLO has a market cap of 158.9M. Regarding current trading prices, HGYN is priced at $0.08, while TGLO trades at $0.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HGYN currently has a P/E ratio of N/A, whereas TGLO's P/E ratio is N/A. In terms of profitability, HGYN's ROE is -0.43%, compared to TGLO's ROE of +0.29%. Regarding short-term risk, HGYN is less volatile compared to TGLO. This indicates potentially lower risk in terms of short-term price fluctuations for HGYN.Check TGLO's competition here
HGYN vs SCGX Comparison May 2026
HGYN plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HGYN stands at 6M. In comparison, SCGX has a market cap of 140.7M. Regarding current trading prices, HGYN is priced at $0.08, while SCGX trades at $7.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HGYN currently has a P/E ratio of N/A, whereas SCGX's P/E ratio is -0.01. In terms of profitability, HGYN's ROE is -0.43%, compared to SCGX's ROE of -0.26%. Regarding short-term risk, HGYN is more volatile compared to SCGX. This indicates potentially higher risk in terms of short-term price fluctuations for HGYN.Check SCGX's competition here
HGYN vs DVTC Comparison May 2026
HGYN plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HGYN stands at 6M. In comparison, DVTC has a market cap of 110.1M. Regarding current trading prices, HGYN is priced at $0.08, while DVTC trades at $2.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HGYN currently has a P/E ratio of N/A, whereas DVTC's P/E ratio is N/A. In terms of profitability, HGYN's ROE is -0.43%, compared to DVTC's ROE of N/A. Regarding short-term risk, HGYN is less volatile compared to DVTC. This indicates potentially lower risk in terms of short-term price fluctuations for HGYN.Check DVTC's competition here
HGYN vs CNXX Comparison May 2026
HGYN plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HGYN stands at 6M. In comparison, CNXX has a market cap of 105.1M. Regarding current trading prices, HGYN is priced at $0.08, while CNXX trades at $5.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HGYN currently has a P/E ratio of N/A, whereas CNXX's P/E ratio is 46.25. In terms of profitability, HGYN's ROE is -0.43%, compared to CNXX's ROE of +8.72%. Regarding short-term risk, HGYN is more volatile compared to CNXX. This indicates potentially higher risk in terms of short-term price fluctuations for HGYN.Check CNXX's competition here
HGYN vs TRFE Comparison May 2026
HGYN plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HGYN stands at 6M. In comparison, TRFE has a market cap of 101M. Regarding current trading prices, HGYN is priced at $0.08, while TRFE trades at $0.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HGYN currently has a P/E ratio of N/A, whereas TRFE's P/E ratio is -1.92. In terms of profitability, HGYN's ROE is -0.43%, compared to TRFE's ROE of -1.73%. Regarding short-term risk, HGYN is more volatile compared to TRFE. This indicates potentially higher risk in terms of short-term price fluctuations for HGYN.Check TRFE's competition here
HGYN vs NMTT Comparison May 2026
HGYN plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HGYN stands at 6M. In comparison, NMTT has a market cap of 90.6M. Regarding current trading prices, HGYN is priced at $0.08, while NMTT trades at $1.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HGYN currently has a P/E ratio of N/A, whereas NMTT's P/E ratio is N/A. In terms of profitability, HGYN's ROE is -0.43%, compared to NMTT's ROE of N/A. Regarding short-term risk, HGYN is more volatile compared to NMTT. This indicates potentially higher risk in terms of short-term price fluctuations for HGYN.Check NMTT's competition here
HGYN vs RMGCF Comparison May 2026
HGYN plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HGYN stands at 6M. In comparison, RMGCF has a market cap of 89.2M. Regarding current trading prices, HGYN is priced at $0.08, while RMGCF trades at $7.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HGYN currently has a P/E ratio of N/A, whereas RMGCF's P/E ratio is -14.41. In terms of profitability, HGYN's ROE is -0.43%, compared to RMGCF's ROE of +0.03%. Regarding short-term risk, HGYN is less volatile compared to RMGCF. This indicates potentially lower risk in terms of short-term price fluctuations for HGYN.Check RMGCF's competition here
HGYN vs GARLF Comparison May 2026
HGYN plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HGYN stands at 6M. In comparison, GARLF has a market cap of 88.5M. Regarding current trading prices, HGYN is priced at $0.08, while GARLF trades at $2.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HGYN currently has a P/E ratio of N/A, whereas GARLF's P/E ratio is -8.29. In terms of profitability, HGYN's ROE is -0.43%, compared to GARLF's ROE of -0.59%. Regarding short-term risk, HGYN is more volatile compared to GARLF. This indicates potentially higher risk in terms of short-term price fluctuations for HGYN.Check GARLF's competition here
HGYN vs ISRLF Comparison May 2026
HGYN plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HGYN stands at 6M. In comparison, ISRLF has a market cap of 86.8M. Regarding current trading prices, HGYN is priced at $0.08, while ISRLF trades at $12.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HGYN currently has a P/E ratio of N/A, whereas ISRLF's P/E ratio is N/A. In terms of profitability, HGYN's ROE is -0.43%, compared to ISRLF's ROE of +0.20%. Regarding short-term risk, HGYN is more volatile compared to ISRLF. This indicates potentially higher risk in terms of short-term price fluctuations for HGYN.Check ISRLF's competition here
HGYN vs WAYS Comparison May 2026
HGYN plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HGYN stands at 6M. In comparison, WAYS has a market cap of 86.5M. Regarding current trading prices, HGYN is priced at $0.08, while WAYS trades at $4.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HGYN currently has a P/E ratio of N/A, whereas WAYS's P/E ratio is -49.72. In terms of profitability, HGYN's ROE is -0.43%, compared to WAYS's ROE of -0.14%. Regarding short-term risk, HGYN is more volatile compared to WAYS. This indicates potentially higher risk in terms of short-term price fluctuations for HGYN.Check WAYS's competition here
HGYN vs USCTF Comparison May 2026
HGYN plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HGYN stands at 6M. In comparison, USCTF has a market cap of 85.9M. Regarding current trading prices, HGYN is priced at $0.08, while USCTF trades at $1.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HGYN currently has a P/E ratio of N/A, whereas USCTF's P/E ratio is -19.00. In terms of profitability, HGYN's ROE is -0.43%, compared to USCTF's ROE of +0.94%. Regarding short-term risk, HGYN is more volatile compared to USCTF. This indicates potentially higher risk in terms of short-term price fluctuations for HGYN.Check USCTF's competition here
HGYN vs ATAQF Comparison May 2026
HGYN plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HGYN stands at 6M. In comparison, ATAQF has a market cap of 82.4M. Regarding current trading prices, HGYN is priced at $0.08, while ATAQF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HGYN currently has a P/E ratio of N/A, whereas ATAQF's P/E ratio is N/A. In terms of profitability, HGYN's ROE is -0.43%, compared to ATAQF's ROE of +0.07%. Regarding short-term risk, HGYN is less volatile compared to ATAQF. This indicates potentially lower risk in terms of short-term price fluctuations for HGYN.Check ATAQF's competition here
HGYN vs WWHC Comparison May 2026
HGYN plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HGYN stands at 6M. In comparison, WWHC has a market cap of 80.2M. Regarding current trading prices, HGYN is priced at $0.08, while WWHC trades at $0.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HGYN currently has a P/E ratio of N/A, whereas WWHC's P/E ratio is -2.11. In terms of profitability, HGYN's ROE is -0.43%, compared to WWHC's ROE of +1.06%. Regarding short-term risk, HGYN is more volatile compared to WWHC. This indicates potentially higher risk in terms of short-term price fluctuations for HGYN.Check WWHC's competition here
HGYN vs IVCAF Comparison May 2026
HGYN plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HGYN stands at 6M. In comparison, IVCAF has a market cap of 77.9M. Regarding current trading prices, HGYN is priced at $0.08, while IVCAF trades at $12.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HGYN currently has a P/E ratio of N/A, whereas IVCAF's P/E ratio is -600.00. In terms of profitability, HGYN's ROE is -0.43%, compared to IVCAF's ROE of -0.01%. Regarding short-term risk, HGYN is more volatile compared to IVCAF. This indicates potentially higher risk in terms of short-term price fluctuations for HGYN.Check IVCAF's competition here
HGYN vs CHAAW Comparison May 2026
HGYN plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HGYN stands at 6M. In comparison, CHAAW has a market cap of 77.6M. Regarding current trading prices, HGYN is priced at $0.08, while CHAAW trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HGYN currently has a P/E ratio of N/A, whereas CHAAW's P/E ratio is N/A. In terms of profitability, HGYN's ROE is -0.43%, compared to CHAAW's ROE of -0.04%. Regarding short-term risk, HGYN is more volatile compared to CHAAW. This indicates potentially higher risk in terms of short-term price fluctuations for HGYN.Check CHAAW's competition here
HGYN vs CREEF Comparison May 2026
HGYN plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HGYN stands at 6M. In comparison, CREEF has a market cap of 75M. Regarding current trading prices, HGYN is priced at $0.08, while CREEF trades at $10.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HGYN currently has a P/E ratio of N/A, whereas CREEF's P/E ratio is 36.47. In terms of profitability, HGYN's ROE is -0.43%, compared to CREEF's ROE of +0.08%. Regarding short-term risk, HGYN is more volatile compared to CREEF. This indicates potentially higher risk in terms of short-term price fluctuations for HGYN.Check CREEF's competition here
HGYN vs IXAQF Comparison May 2026
HGYN plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HGYN stands at 6M. In comparison, IXAQF has a market cap of 74.2M. Regarding current trading prices, HGYN is priced at $0.08, while IXAQF trades at $11.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HGYN currently has a P/E ratio of N/A, whereas IXAQF's P/E ratio is -82.14. In terms of profitability, HGYN's ROE is -0.43%, compared to IXAQF's ROE of +0.08%. Regarding short-term risk, HGYN is more volatile compared to IXAQF. This indicates potentially higher risk in terms of short-term price fluctuations for HGYN.Check IXAQF's competition here
HGYN vs XTPT Comparison May 2026
HGYN plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HGYN stands at 6M. In comparison, XTPT has a market cap of 74M. Regarding current trading prices, HGYN is priced at $0.08, while XTPT trades at $0.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HGYN currently has a P/E ratio of N/A, whereas XTPT's P/E ratio is N/A. In terms of profitability, HGYN's ROE is -0.43%, compared to XTPT's ROE of -8.42%. Regarding short-term risk, HGYN is more volatile compared to XTPT. This indicates potentially higher risk in terms of short-term price fluctuations for HGYN.Check XTPT's competition here
HGYN vs ASCBF Comparison May 2026
HGYN plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HGYN stands at 6M. In comparison, ASCBF has a market cap of 68.9M. Regarding current trading prices, HGYN is priced at $0.08, while ASCBF trades at $13.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HGYN currently has a P/E ratio of N/A, whereas ASCBF's P/E ratio is 26.81. In terms of profitability, HGYN's ROE is -0.43%, compared to ASCBF's ROE of +0.03%. Regarding short-term risk, HGYN is more volatile compared to ASCBF. This indicates potentially higher risk in terms of short-term price fluctuations for HGYN.Check ASCBF's competition here
HGYN vs HAIAF Comparison May 2026
HGYN plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HGYN stands at 6M. In comparison, HAIAF has a market cap of 60.2M. Regarding current trading prices, HGYN is priced at $0.08, while HAIAF trades at $10.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HGYN currently has a P/E ratio of N/A, whereas HAIAF's P/E ratio is -217.20. In terms of profitability, HGYN's ROE is -0.43%, compared to HAIAF's ROE of -0.16%. Regarding short-term risk, HGYN is more volatile compared to HAIAF. This indicates potentially higher risk in terms of short-term price fluctuations for HGYN.Check HAIAF's competition here
HGYN vs PTCP Comparison May 2026
HGYN plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HGYN stands at 6M. In comparison, PTCP has a market cap of 56.7M. Regarding current trading prices, HGYN is priced at $0.08, while PTCP trades at $2.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HGYN currently has a P/E ratio of N/A, whereas PTCP's P/E ratio is -27.78. In terms of profitability, HGYN's ROE is -0.43%, compared to PTCP's ROE of N/A. Regarding short-term risk, HGYN is more volatile compared to PTCP. This indicates potentially higher risk in terms of short-term price fluctuations for HGYN.Check PTCP's competition here
HGYN vs ATMS Comparison May 2026
HGYN plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HGYN stands at 6M. In comparison, ATMS has a market cap of 55.8M. Regarding current trading prices, HGYN is priced at $0.08, while ATMS trades at $0.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HGYN currently has a P/E ratio of N/A, whereas ATMS's P/E ratio is -8.30. In terms of profitability, HGYN's ROE is -0.43%, compared to ATMS's ROE of +1.78%. Regarding short-term risk, HGYN is more volatile compared to ATMS. This indicates potentially higher risk in terms of short-term price fluctuations for HGYN.Check ATMS's competition here
HGYN vs AASP Comparison May 2026
HGYN plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HGYN stands at 6M. In comparison, AASP has a market cap of 53.5M. Regarding current trading prices, HGYN is priced at $0.08, while AASP trades at $5.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HGYN currently has a P/E ratio of N/A, whereas AASP's P/E ratio is -5.67. In terms of profitability, HGYN's ROE is -0.43%, compared to AASP's ROE of -6.40%. Regarding short-term risk, HGYN is more volatile compared to AASP. This indicates potentially higher risk in terms of short-term price fluctuations for HGYN.Check AASP's competition here
HGYN vs GGAAF Comparison May 2026
HGYN plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HGYN stands at 6M. In comparison, GGAAF has a market cap of 50.7M. Regarding current trading prices, HGYN is priced at $0.08, while GGAAF trades at $8.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HGYN currently has a P/E ratio of N/A, whereas GGAAF's P/E ratio is -133.33. In terms of profitability, HGYN's ROE is -0.43%, compared to GGAAF's ROE of +0.00%. Regarding short-term risk, HGYN is more volatile compared to GGAAF. This indicates potentially higher risk in terms of short-term price fluctuations for HGYN.Check GGAAF's competition here
HGYN vs AOAO Comparison May 2026
HGYN plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HGYN stands at 6M. In comparison, AOAO has a market cap of 48.3M. Regarding current trading prices, HGYN is priced at $0.08, while AOAO trades at $4.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HGYN currently has a P/E ratio of N/A, whereas AOAO's P/E ratio is -4.52. In terms of profitability, HGYN's ROE is -0.43%, compared to AOAO's ROE of +9.96%. Regarding short-term risk, HGYN is more volatile compared to AOAO. This indicates potentially higher risk in terms of short-term price fluctuations for HGYN.Check AOAO's competition here
HGYN vs JMTM Comparison May 2026
HGYN plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HGYN stands at 6M. In comparison, JMTM has a market cap of 48M. Regarding current trading prices, HGYN is priced at $0.08, while JMTM trades at $5.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HGYN currently has a P/E ratio of N/A, whereas JMTM's P/E ratio is -10.00. In terms of profitability, HGYN's ROE is -0.43%, compared to JMTM's ROE of +3.01%. Regarding short-term risk, HGYN is more volatile compared to JMTM. This indicates potentially higher risk in terms of short-term price fluctuations for HGYN.Check JMTM's competition here
HGYN vs KWAC Comparison May 2026
HGYN plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HGYN stands at 6M. In comparison, KWAC has a market cap of 46.2M. Regarding current trading prices, HGYN is priced at $0.08, while KWAC trades at $13.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HGYN currently has a P/E ratio of N/A, whereas KWAC's P/E ratio is -23.75. In terms of profitability, HGYN's ROE is -0.43%, compared to KWAC's ROE of +0.03%. Regarding short-term risk, HGYN is more volatile compared to KWAC. This indicates potentially higher risk in terms of short-term price fluctuations for HGYN.Check KWAC's competition here
HGYN vs KWACW Comparison May 2026
HGYN plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HGYN stands at 6M. In comparison, KWACW has a market cap of 46.2M. Regarding current trading prices, HGYN is priced at $0.08, while KWACW trades at $0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HGYN currently has a P/E ratio of N/A, whereas KWACW's P/E ratio is N/A. In terms of profitability, HGYN's ROE is -0.43%, compared to KWACW's ROE of +0.03%. Regarding short-term risk, HGYN is more volatile compared to KWACW. This indicates potentially higher risk in terms of short-term price fluctuations for HGYN.Check KWACW's competition here
HGYN vs TETEF Comparison May 2026
HGYN plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HGYN stands at 6M. In comparison, TETEF has a market cap of 44.5M. Regarding current trading prices, HGYN is priced at $0.08, while TETEF trades at $13.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HGYN currently has a P/E ratio of N/A, whereas TETEF's P/E ratio is 433.67. In terms of profitability, HGYN's ROE is -0.43%, compared to TETEF's ROE of +0.11%. Regarding short-term risk, HGYN is more volatile compared to TETEF. This indicates potentially higher risk in terms of short-term price fluctuations for HGYN.Check TETEF's competition here
HGYN vs FSTJ Comparison May 2026
HGYN plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HGYN stands at 6M. In comparison, FSTJ has a market cap of 44M. Regarding current trading prices, HGYN is priced at $0.08, while FSTJ trades at $0.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HGYN currently has a P/E ratio of N/A, whereas FSTJ's P/E ratio is -50.00. In terms of profitability, HGYN's ROE is -0.43%, compared to FSTJ's ROE of +0.24%. Regarding short-term risk, HGYN is more volatile compared to FSTJ. This indicates potentially higher risk in terms of short-term price fluctuations for HGYN.Check FSTJ's competition here
HGYN vs MSSAF Comparison May 2026
HGYN plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HGYN stands at 6M. In comparison, MSSAF has a market cap of 40.8M. Regarding current trading prices, HGYN is priced at $0.08, while MSSAF trades at $12.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HGYN currently has a P/E ratio of N/A, whereas MSSAF's P/E ratio is -6.10. In terms of profitability, HGYN's ROE is -0.43%, compared to MSSAF's ROE of +0.09%. Regarding short-term risk, HGYN is more volatile compared to MSSAF. This indicates potentially higher risk in terms of short-term price fluctuations for HGYN.Check MSSAF's competition here
HGYN vs ACBD Comparison May 2026
HGYN plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HGYN stands at 6M. In comparison, ACBD has a market cap of 34.1M. Regarding current trading prices, HGYN is priced at $0.08, while ACBD trades at $0.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HGYN currently has a P/E ratio of N/A, whereas ACBD's P/E ratio is N/A. In terms of profitability, HGYN's ROE is -0.43%, compared to ACBD's ROE of +1.16%. Regarding short-term risk, HGYN is more volatile compared to ACBD. This indicates potentially higher risk in terms of short-term price fluctuations for HGYN.Check ACBD's competition here
HGYN vs AVNI Comparison May 2026
HGYN plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HGYN stands at 6M. In comparison, AVNI has a market cap of 31.3M. Regarding current trading prices, HGYN is priced at $0.08, while AVNI trades at $0.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HGYN currently has a P/E ratio of N/A, whereas AVNI's P/E ratio is -24.86. In terms of profitability, HGYN's ROE is -0.43%, compared to AVNI's ROE of +1.17%. Regarding short-term risk, HGYN is more volatile compared to AVNI. This indicates potentially higher risk in terms of short-term price fluctuations for HGYN.Check AVNI's competition here
HGYN vs CLRCF Comparison May 2026
HGYN plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HGYN stands at 6M. In comparison, CLRCF has a market cap of 30.6M. Regarding current trading prices, HGYN is priced at $0.08, while CLRCF trades at $12.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HGYN currently has a P/E ratio of N/A, whereas CLRCF's P/E ratio is -35.44. In terms of profitability, HGYN's ROE is -0.43%, compared to CLRCF's ROE of +0.09%. Regarding short-term risk, HGYN is more volatile compared to CLRCF. This indicates potentially higher risk in terms of short-term price fluctuations for HGYN.Check CLRCF's competition here
HGYN vs WBQNL Comparison May 2026
HGYN plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HGYN stands at 6M. In comparison, WBQNL has a market cap of 29M. Regarding current trading prices, HGYN is priced at $0.08, while WBQNL trades at $2.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HGYN currently has a P/E ratio of N/A, whereas WBQNL's P/E ratio is N/A. In terms of profitability, HGYN's ROE is -0.43%, compared to WBQNL's ROE of +0.00%. Regarding short-term risk, HGYN is more volatile compared to WBQNL. This indicates potentially higher risk in terms of short-term price fluctuations for HGYN.Check WBQNL's competition here
HGYN vs IDIG Comparison May 2026
HGYN plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HGYN stands at 6M. In comparison, IDIG has a market cap of 27.2M. Regarding current trading prices, HGYN is priced at $0.08, while IDIG trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HGYN currently has a P/E ratio of N/A, whereas IDIG's P/E ratio is N/A. In terms of profitability, HGYN's ROE is -0.43%, compared to IDIG's ROE of N/A. Regarding short-term risk, HGYN is more volatile compared to IDIG. This indicates potentially higher risk in terms of short-term price fluctuations for HGYN.Check IDIG's competition here
HGYN vs CHYL Comparison May 2026
HGYN plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HGYN stands at 6M. In comparison, CHYL has a market cap of 27.1M. Regarding current trading prices, HGYN is priced at $0.08, while CHYL trades at $0.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HGYN currently has a P/E ratio of N/A, whereas CHYL's P/E ratio is 45.75. In terms of profitability, HGYN's ROE is -0.43%, compared to CHYL's ROE of +0.23%. Regarding short-term risk, HGYN is more volatile compared to CHYL. This indicates potentially higher risk in terms of short-term price fluctuations for HGYN.Check CHYL's competition here
HGYN vs ADCV Comparison May 2026
HGYN plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HGYN stands at 6M. In comparison, ADCV has a market cap of 26.7M. Regarding current trading prices, HGYN is priced at $0.08, while ADCV trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HGYN currently has a P/E ratio of N/A, whereas ADCV's P/E ratio is -0.64. In terms of profitability, HGYN's ROE is -0.43%, compared to ADCV's ROE of N/A. Regarding short-term risk, HGYN is more volatile compared to ADCV. This indicates potentially higher risk in terms of short-term price fluctuations for HGYN.Check ADCV's competition here
HGYN vs NPFC Comparison May 2026
HGYN plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HGYN stands at 6M. In comparison, NPFC has a market cap of 23.9M. Regarding current trading prices, HGYN is priced at $0.08, while NPFC trades at $1.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HGYN currently has a P/E ratio of N/A, whereas NPFC's P/E ratio is -17.86. In terms of profitability, HGYN's ROE is -0.43%, compared to NPFC's ROE of +1.75%. Regarding short-term risk, HGYN is more volatile compared to NPFC. This indicates potentially higher risk in terms of short-term price fluctuations for HGYN.Check NPFC's competition here
HGYN vs AZRH Comparison May 2026
HGYN plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HGYN stands at 6M. In comparison, AZRH has a market cap of 23.7M. Regarding current trading prices, HGYN is priced at $0.08, while AZRH trades at $0.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HGYN currently has a P/E ratio of N/A, whereas AZRH's P/E ratio is N/A. In terms of profitability, HGYN's ROE is -0.43%, compared to AZRH's ROE of -0.09%. Regarding short-term risk, HGYN is less volatile compared to AZRH. This indicates potentially lower risk in terms of short-term price fluctuations for HGYN.Check AZRH's competition here
HGYN vs ATMH Comparison May 2026
HGYN plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HGYN stands at 6M. In comparison, ATMH has a market cap of 22.8M. Regarding current trading prices, HGYN is priced at $0.08, while ATMH trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HGYN currently has a P/E ratio of N/A, whereas ATMH's P/E ratio is -4.20. In terms of profitability, HGYN's ROE is -0.43%, compared to ATMH's ROE of -0.36%. Regarding short-term risk, HGYN is more volatile compared to ATMH. This indicates potentially higher risk in terms of short-term price fluctuations for HGYN.Check ATMH's competition here
HGYN vs CBBB Comparison May 2026
HGYN plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HGYN stands at 6M. In comparison, CBBB has a market cap of 22.1M. Regarding current trading prices, HGYN is priced at $0.08, while CBBB trades at $0.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HGYN currently has a P/E ratio of N/A, whereas CBBB's P/E ratio is -0.87. In terms of profitability, HGYN's ROE is -0.43%, compared to CBBB's ROE of +0.00%. Regarding short-term risk, HGYN is less volatile compared to CBBB. This indicates potentially lower risk in terms of short-term price fluctuations for HGYN.Check CBBB's competition here
HGYN vs GIPL Comparison May 2026
HGYN plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HGYN stands at 6M. In comparison, GIPL has a market cap of 19.8M. Regarding current trading prices, HGYN is priced at $0.08, while GIPL trades at $0.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HGYN currently has a P/E ratio of N/A, whereas GIPL's P/E ratio is N/A. In terms of profitability, HGYN's ROE is -0.43%, compared to GIPL's ROE of -3.74%. Regarding short-term risk, HGYN is more volatile compared to GIPL. This indicates potentially higher risk in terms of short-term price fluctuations for HGYN.Check GIPL's competition here
HGYN vs MDWK Comparison May 2026
HGYN plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HGYN stands at 6M. In comparison, MDWK has a market cap of 18.8M. Regarding current trading prices, HGYN is priced at $0.08, while MDWK trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HGYN currently has a P/E ratio of N/A, whereas MDWK's P/E ratio is -4.00. In terms of profitability, HGYN's ROE is -0.43%, compared to MDWK's ROE of -2.80%. Regarding short-term risk, HGYN is more volatile compared to MDWK. This indicates potentially higher risk in terms of short-term price fluctuations for HGYN.Check MDWK's competition here
HGYN vs CMCAF Comparison May 2026
HGYN plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HGYN stands at 6M. In comparison, CMCAF has a market cap of 18.8M. Regarding current trading prices, HGYN is priced at $0.08, while CMCAF trades at $3.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HGYN currently has a P/E ratio of N/A, whereas CMCAF's P/E ratio is 11.25. In terms of profitability, HGYN's ROE is -0.43%, compared to CMCAF's ROE of +5.07%. Regarding short-term risk, HGYN is more volatile compared to CMCAF. This indicates potentially higher risk in terms of short-term price fluctuations for HGYN.Check CMCAF's competition here
HGYN vs EVTK Comparison May 2026
HGYN plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HGYN stands at 6M. In comparison, EVTK has a market cap of 16.8M. Regarding current trading prices, HGYN is priced at $0.08, while EVTK trades at $4.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HGYN currently has a P/E ratio of N/A, whereas EVTK's P/E ratio is -400.00. In terms of profitability, HGYN's ROE is -0.43%, compared to EVTK's ROE of +0.61%. Regarding short-term risk, HGYN is more volatile compared to EVTK. This indicates potentially higher risk in terms of short-term price fluctuations for HGYN.Check EVTK's competition here
HGYN vs SIPN Comparison May 2026
HGYN plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HGYN stands at 6M. In comparison, SIPN has a market cap of 16.2M. Regarding current trading prices, HGYN is priced at $0.08, while SIPN trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HGYN currently has a P/E ratio of N/A, whereas SIPN's P/E ratio is N/A. In terms of profitability, HGYN's ROE is -0.43%, compared to SIPN's ROE of +0.01%. Regarding short-term risk, HGYN is more volatile compared to SIPN. This indicates potentially higher risk in terms of short-term price fluctuations for HGYN.Check SIPN's competition here
HGYN vs ADIA Comparison May 2026
HGYN plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HGYN stands at 6M. In comparison, ADIA has a market cap of 16M. Regarding current trading prices, HGYN is priced at $0.08, while ADIA trades at $0.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HGYN currently has a P/E ratio of N/A, whereas ADIA's P/E ratio is -0.42. In terms of profitability, HGYN's ROE is -0.43%, compared to ADIA's ROE of +3.07%. Regarding short-term risk, HGYN is more volatile compared to ADIA. This indicates potentially higher risk in terms of short-term price fluctuations for HGYN.Check ADIA's competition here
HGYN vs GTVI Comparison May 2026
HGYN plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HGYN stands at 6M. In comparison, GTVI has a market cap of 15.3M. Regarding current trading prices, HGYN is priced at $0.08, while GTVI trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HGYN currently has a P/E ratio of N/A, whereas GTVI's P/E ratio is -3.65. In terms of profitability, HGYN's ROE is -0.43%, compared to GTVI's ROE of +0.38%. Regarding short-term risk, HGYN is more volatile compared to GTVI. This indicates potentially higher risk in terms of short-term price fluctuations for HGYN.Check GTVI's competition here
HGYN vs CAHO Comparison May 2026
HGYN plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HGYN stands at 6M. In comparison, CAHO has a market cap of 14.9M. Regarding current trading prices, HGYN is priced at $0.08, while CAHO trades at $0.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HGYN currently has a P/E ratio of N/A, whereas CAHO's P/E ratio is -40.00. In terms of profitability, HGYN's ROE is -0.43%, compared to CAHO's ROE of +0.40%. Regarding short-term risk, HGYN is more volatile compared to CAHO. This indicates potentially higher risk in terms of short-term price fluctuations for HGYN.Check CAHO's competition here
HGYN vs WRPT Comparison May 2026
HGYN plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HGYN stands at 6M. In comparison, WRPT has a market cap of 14.7M. Regarding current trading prices, HGYN is priced at $0.08, while WRPT trades at $0.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HGYN currently has a P/E ratio of N/A, whereas WRPT's P/E ratio is N/A. In terms of profitability, HGYN's ROE is -0.43%, compared to WRPT's ROE of -0.06%. Regarding short-term risk, HGYN is more volatile compared to WRPT. This indicates potentially higher risk in terms of short-term price fluctuations for HGYN.Check WRPT's competition here
HGYN vs BTOW Comparison May 2026
HGYN plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HGYN stands at 6M. In comparison, BTOW has a market cap of 14.2M. Regarding current trading prices, HGYN is priced at $0.08, while BTOW trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HGYN currently has a P/E ratio of N/A, whereas BTOW's P/E ratio is -0.10. In terms of profitability, HGYN's ROE is -0.43%, compared to BTOW's ROE of +0.00%. Regarding short-term risk, HGYN is more volatile compared to BTOW. This indicates potentially higher risk in terms of short-term price fluctuations for HGYN.Check BTOW's competition here
HGYN vs ECGR Comparison May 2026
HGYN plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HGYN stands at 6M. In comparison, ECGR has a market cap of 13.4M. Regarding current trading prices, HGYN is priced at $0.08, while ECGR trades at $0.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HGYN currently has a P/E ratio of N/A, whereas ECGR's P/E ratio is -20.00. In terms of profitability, HGYN's ROE is -0.43%, compared to ECGR's ROE of -1.14%. Regarding short-term risk, HGYN is more volatile compared to ECGR. This indicates potentially higher risk in terms of short-term price fluctuations for HGYN.Check ECGR's competition here
HGYN vs USBL Comparison May 2026
HGYN plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HGYN stands at 6M. In comparison, USBL has a market cap of 13.1M. Regarding current trading prices, HGYN is priced at $0.08, while USBL trades at $0.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HGYN currently has a P/E ratio of N/A, whereas USBL's P/E ratio is -0.81. In terms of profitability, HGYN's ROE is -0.43%, compared to USBL's ROE of +0.12%. Regarding short-term risk, HGYN is more volatile compared to USBL. This indicates potentially higher risk in terms of short-term price fluctuations for HGYN.Check USBL's competition here
HGYN vs LNMG Comparison May 2026
HGYN plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HGYN stands at 6M. In comparison, LNMG has a market cap of 13M. Regarding current trading prices, HGYN is priced at $0.08, while LNMG trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HGYN currently has a P/E ratio of N/A, whereas LNMG's P/E ratio is 2.55. In terms of profitability, HGYN's ROE is -0.43%, compared to LNMG's ROE of +0.02%. Regarding short-term risk, HGYN is more volatile compared to LNMG. This indicates potentially higher risk in terms of short-term price fluctuations for HGYN.Check LNMG's competition here
HGYN vs XITO Comparison May 2026
HGYN plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HGYN stands at 6M. In comparison, XITO has a market cap of 12.9M. Regarding current trading prices, HGYN is priced at $0.08, while XITO trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HGYN currently has a P/E ratio of N/A, whereas XITO's P/E ratio is N/A. In terms of profitability, HGYN's ROE is -0.43%, compared to XITO's ROE of +0.28%. Regarding short-term risk, HGYN is more volatile compared to XITO. This indicates potentially higher risk in terms of short-term price fluctuations for HGYN.Check XITO's competition here
HGYN vs LRGR Comparison May 2026
HGYN plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HGYN stands at 6M. In comparison, LRGR has a market cap of 12.5M. Regarding current trading prices, HGYN is priced at $0.08, while LRGR trades at $0.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HGYN currently has a P/E ratio of N/A, whereas LRGR's P/E ratio is -0.02. In terms of profitability, HGYN's ROE is -0.43%, compared to LRGR's ROE of +0.15%. Regarding short-term risk, HGYN is more volatile compared to LRGR. This indicates potentially higher risk in terms of short-term price fluctuations for HGYN.Check LRGR's competition here
HGYN vs CMCUF Comparison May 2026
HGYN plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HGYN stands at 6M. In comparison, CMCUF has a market cap of 11.8M. Regarding current trading prices, HGYN is priced at $0.08, while CMCUF trades at $2.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HGYN currently has a P/E ratio of N/A, whereas CMCUF's P/E ratio is N/A. In terms of profitability, HGYN's ROE is -0.43%, compared to CMCUF's ROE of +5.07%. Regarding short-term risk, HGYN is more volatile compared to CMCUF. This indicates potentially higher risk in terms of short-term price fluctuations for HGYN.Check CMCUF's competition here
HGYN vs STLY Comparison May 2026
HGYN plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HGYN stands at 6M. In comparison, STLY has a market cap of 11.6M. Regarding current trading prices, HGYN is priced at $0.08, while STLY trades at $4.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HGYN currently has a P/E ratio of N/A, whereas STLY's P/E ratio is 10.90. In terms of profitability, HGYN's ROE is -0.43%, compared to STLY's ROE of +0.04%. Regarding short-term risk, HGYN is more volatile compared to STLY. This indicates potentially higher risk in terms of short-term price fluctuations for HGYN.Check STLY's competition here
HGYN vs PCMC Comparison May 2026
HGYN plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HGYN stands at 6M. In comparison, PCMC has a market cap of 11.3M. Regarding current trading prices, HGYN is priced at $0.08, while PCMC trades at $0.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HGYN currently has a P/E ratio of N/A, whereas PCMC's P/E ratio is -1.65. In terms of profitability, HGYN's ROE is -0.43%, compared to PCMC's ROE of +0.22%. Regarding short-term risk, HGYN is more volatile compared to PCMC. This indicates potentially higher risk in terms of short-term price fluctuations for HGYN.Check PCMC's competition here
HGYN vs PSCO Comparison May 2026
HGYN plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HGYN stands at 6M. In comparison, PSCO has a market cap of 10.7M. Regarding current trading prices, HGYN is priced at $0.08, while PSCO trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HGYN currently has a P/E ratio of N/A, whereas PSCO's P/E ratio is -0.42. In terms of profitability, HGYN's ROE is -0.43%, compared to PSCO's ROE of +0.00%. Regarding short-term risk, HGYN is more volatile compared to PSCO. This indicates potentially higher risk in terms of short-term price fluctuations for HGYN.Check PSCO's competition here
HGYN vs FWFW Comparison May 2026
HGYN plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HGYN stands at 6M. In comparison, FWFW has a market cap of 10.3M. Regarding current trading prices, HGYN is priced at $0.08, while FWFW trades at $0.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HGYN currently has a P/E ratio of N/A, whereas FWFW's P/E ratio is -1.83. In terms of profitability, HGYN's ROE is -0.43%, compared to FWFW's ROE of -2.72%. Regarding short-term risk, HGYN is more volatile compared to FWFW. This indicates potentially higher risk in terms of short-term price fluctuations for HGYN.Check FWFW's competition here
HGYN vs ELLH Comparison May 2026
HGYN plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HGYN stands at 6M. In comparison, ELLH has a market cap of 9.9M. Regarding current trading prices, HGYN is priced at $0.08, while ELLH trades at $13.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HGYN currently has a P/E ratio of N/A, whereas ELLH's P/E ratio is -4.13. In terms of profitability, HGYN's ROE is -0.43%, compared to ELLH's ROE of -0.40%. Regarding short-term risk, HGYN is more volatile compared to ELLH. This indicates potentially higher risk in terms of short-term price fluctuations for HGYN.Check ELLH's competition here
HGYN vs BOREF Comparison May 2026
HGYN plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HGYN stands at 6M. In comparison, BOREF has a market cap of 9.9M. Regarding current trading prices, HGYN is priced at $0.08, while BOREF trades at $2.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HGYN currently has a P/E ratio of N/A, whereas BOREF's P/E ratio is -22.22. In terms of profitability, HGYN's ROE is -0.43%, compared to BOREF's ROE of +0.06%. Regarding short-term risk, HGYN is more volatile compared to BOREF. This indicates potentially higher risk in terms of short-term price fluctuations for HGYN.Check BOREF's competition here
HGYN vs WNFT Comparison May 2026
HGYN plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HGYN stands at 6M. In comparison, WNFT has a market cap of 9.4M. Regarding current trading prices, HGYN is priced at $0.08, while WNFT trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HGYN currently has a P/E ratio of N/A, whereas WNFT's P/E ratio is N/A. In terms of profitability, HGYN's ROE is -0.43%, compared to WNFT's ROE of +0.00%. Regarding short-term risk, HGYN is more volatile compared to WNFT. This indicates potentially higher risk in terms of short-term price fluctuations for HGYN.Check WNFT's competition here
HGYN vs XCPT Comparison May 2026
HGYN plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HGYN stands at 6M. In comparison, XCPT has a market cap of 9.1M. Regarding current trading prices, HGYN is priced at $0.08, while XCPT trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HGYN currently has a P/E ratio of N/A, whereas XCPT's P/E ratio is N/A. In terms of profitability, HGYN's ROE is -0.43%, compared to XCPT's ROE of N/A. Regarding short-term risk, HGYN is more volatile compared to XCPT. This indicates potentially higher risk in terms of short-term price fluctuations for HGYN.Check XCPT's competition here
HGYN vs AWCA Comparison May 2026
HGYN plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HGYN stands at 6M. In comparison, AWCA has a market cap of 8.8M. Regarding current trading prices, HGYN is priced at $0.08, while AWCA trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HGYN currently has a P/E ratio of N/A, whereas AWCA's P/E ratio is -2.16. In terms of profitability, HGYN's ROE is -0.43%, compared to AWCA's ROE of -0.41%. Regarding short-term risk, HGYN is more volatile compared to AWCA. This indicates potentially higher risk in terms of short-term price fluctuations for HGYN.Check AWCA's competition here
HGYN vs NIMU Comparison May 2026
HGYN plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HGYN stands at 6M. In comparison, NIMU has a market cap of 8.5M. Regarding current trading prices, HGYN is priced at $0.08, while NIMU trades at $0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HGYN currently has a P/E ratio of N/A, whereas NIMU's P/E ratio is -0.31. In terms of profitability, HGYN's ROE is -0.43%, compared to NIMU's ROE of +0.20%. Regarding short-term risk, HGYN is more volatile compared to NIMU. This indicates potentially higher risk in terms of short-term price fluctuations for HGYN.Check NIMU's competition here
HGYN vs LWLW Comparison May 2026
HGYN plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HGYN stands at 6M. In comparison, LWLW has a market cap of 8.1M. Regarding current trading prices, HGYN is priced at $0.08, while LWLW trades at $0.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HGYN currently has a P/E ratio of N/A, whereas LWLW's P/E ratio is -10.00. In terms of profitability, HGYN's ROE is -0.43%, compared to LWLW's ROE of +176.01%. Regarding short-term risk, HGYN is more volatile compared to LWLW. This indicates potentially higher risk in terms of short-term price fluctuations for HGYN.Check LWLW's competition here
HGYN vs RAFX Comparison May 2026
HGYN plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HGYN stands at 6M. In comparison, RAFX has a market cap of 7.9M. Regarding current trading prices, HGYN is priced at $0.08, while RAFX trades at $0.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HGYN currently has a P/E ratio of N/A, whereas RAFX's P/E ratio is N/A. In terms of profitability, HGYN's ROE is -0.43%, compared to RAFX's ROE of -0.06%. Regarding short-term risk, HGYN is more volatile compared to RAFX. This indicates potentially higher risk in terms of short-term price fluctuations for HGYN.Check RAFX's competition here
HGYN vs IGSC Comparison May 2026
HGYN plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HGYN stands at 6M. In comparison, IGSC has a market cap of 7.5M. Regarding current trading prices, HGYN is priced at $0.08, while IGSC trades at $2.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HGYN currently has a P/E ratio of N/A, whereas IGSC's P/E ratio is -0.11. In terms of profitability, HGYN's ROE is -0.43%, compared to IGSC's ROE of +0.12%. Regarding short-term risk, HGYN is more volatile compared to IGSC. This indicates potentially higher risk in terms of short-term price fluctuations for HGYN.Check IGSC's competition here
HGYN vs NXMH Comparison May 2026
HGYN plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HGYN stands at 6M. In comparison, NXMH has a market cap of 7.4M. Regarding current trading prices, HGYN is priced at $0.08, while NXMH trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HGYN currently has a P/E ratio of N/A, whereas NXMH's P/E ratio is -1.69. In terms of profitability, HGYN's ROE is -0.43%, compared to NXMH's ROE of +0.30%. Regarding short-term risk, HGYN is more volatile compared to NXMH. This indicates potentially higher risk in terms of short-term price fluctuations for HGYN.Check NXMH's competition here
HGYN vs ADHI Comparison May 2026
HGYN plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HGYN stands at 6M. In comparison, ADHI has a market cap of 6.8M. Regarding current trading prices, HGYN is priced at $0.08, while ADHI trades at $0.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HGYN currently has a P/E ratio of N/A, whereas ADHI's P/E ratio is -0.04. In terms of profitability, HGYN's ROE is -0.43%, compared to ADHI's ROE of -0.52%. Regarding short-term risk, HGYN is more volatile compared to ADHI. This indicates potentially higher risk in terms of short-term price fluctuations for HGYN.Check ADHI's competition here
HGYN vs ITRX Comparison May 2026
HGYN plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HGYN stands at 6M. In comparison, ITRX has a market cap of 6.5M. Regarding current trading prices, HGYN is priced at $0.08, while ITRX trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HGYN currently has a P/E ratio of N/A, whereas ITRX's P/E ratio is -2.11. In terms of profitability, HGYN's ROE is -0.43%, compared to ITRX's ROE of N/A. Regarding short-term risk, HGYN is more volatile compared to ITRX. This indicates potentially higher risk in terms of short-term price fluctuations for HGYN.Check ITRX's competition here
HGYN vs CAVG Comparison May 2026
HGYN plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HGYN stands at 6M. In comparison, CAVG has a market cap of 6.4M. Regarding current trading prices, HGYN is priced at $0.08, while CAVG trades at $0.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HGYN currently has a P/E ratio of N/A, whereas CAVG's P/E ratio is -7.14. In terms of profitability, HGYN's ROE is -0.43%, compared to CAVG's ROE of +0.89%. Regarding short-term risk, HGYN is less volatile compared to CAVG. This indicates potentially lower risk in terms of short-term price fluctuations for HGYN.Check CAVG's competition here
HGYN vs SDAD Comparison May 2026
HGYN plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HGYN stands at 6M. In comparison, SDAD has a market cap of 6.4M. Regarding current trading prices, HGYN is priced at $0.08, while SDAD trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HGYN currently has a P/E ratio of N/A, whereas SDAD's P/E ratio is N/A. In terms of profitability, HGYN's ROE is -0.43%, compared to SDAD's ROE of N/A. Regarding short-term risk, HGYN is more volatile compared to SDAD. This indicates potentially higher risk in terms of short-term price fluctuations for HGYN.Check SDAD's competition here
HGYN vs ILXP Comparison May 2026
HGYN plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HGYN stands at 6M. In comparison, ILXP has a market cap of 5.9M. Regarding current trading prices, HGYN is priced at $0.08, while ILXP trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HGYN currently has a P/E ratio of N/A, whereas ILXP's P/E ratio is N/A. In terms of profitability, HGYN's ROE is -0.43%, compared to ILXP's ROE of +0.00%. Regarding short-term risk, HGYN is more volatile compared to ILXP. This indicates potentially higher risk in terms of short-term price fluctuations for HGYN.Check ILXP's competition here
HGYN vs EDGM Comparison May 2026
HGYN plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HGYN stands at 6M. In comparison, EDGM has a market cap of 5.6M. Regarding current trading prices, HGYN is priced at $0.08, while EDGM trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HGYN currently has a P/E ratio of N/A, whereas EDGM's P/E ratio is -0.23. In terms of profitability, HGYN's ROE is -0.43%, compared to EDGM's ROE of +2.36%. Regarding short-term risk, HGYN is more volatile compared to EDGM. This indicates potentially higher risk in terms of short-term price fluctuations for HGYN.Check EDGM's competition here
HGYN vs BDCM Comparison May 2026
HGYN plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HGYN stands at 6M. In comparison, BDCM has a market cap of 5.3M. Regarding current trading prices, HGYN is priced at $0.08, while BDCM trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HGYN currently has a P/E ratio of N/A, whereas BDCM's P/E ratio is N/A. In terms of profitability, HGYN's ROE is -0.43%, compared to BDCM's ROE of +10.41%. Regarding short-term risk, HGYN is more volatile compared to BDCM. This indicates potentially higher risk in terms of short-term price fluctuations for HGYN.Check BDCM's competition here
HGYN vs NRCD Comparison May 2026
HGYN plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HGYN stands at 6M. In comparison, NRCD has a market cap of 5.2M. Regarding current trading prices, HGYN is priced at $0.08, while NRCD trades at $0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HGYN currently has a P/E ratio of N/A, whereas NRCD's P/E ratio is N/A. In terms of profitability, HGYN's ROE is -0.43%, compared to NRCD's ROE of N/A. Regarding short-term risk, HGYN is more volatile compared to NRCD. This indicates potentially higher risk in terms of short-term price fluctuations for HGYN.Check NRCD's competition here
HGYN vs SMEV Comparison May 2026
HGYN plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HGYN stands at 6M. In comparison, SMEV has a market cap of 4.9M. Regarding current trading prices, HGYN is priced at $0.08, while SMEV trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HGYN currently has a P/E ratio of N/A, whereas SMEV's P/E ratio is N/A. In terms of profitability, HGYN's ROE is -0.43%, compared to SMEV's ROE of +0.19%. Regarding short-term risk, HGYN is more volatile compared to SMEV. This indicates potentially higher risk in terms of short-term price fluctuations for HGYN.Check SMEV's competition here
HGYN vs ASNB Comparison May 2026
HGYN plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HGYN stands at 6M. In comparison, ASNB has a market cap of 4.8M. Regarding current trading prices, HGYN is priced at $0.08, while ASNB trades at $0.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HGYN currently has a P/E ratio of N/A, whereas ASNB's P/E ratio is -0.60. In terms of profitability, HGYN's ROE is -0.43%, compared to ASNB's ROE of -0.07%. Regarding short-term risk, HGYN is more volatile compared to ASNB. This indicates potentially higher risk in terms of short-term price fluctuations for HGYN.Check ASNB's competition here
HGYN vs MTRI Comparison May 2026
HGYN plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HGYN stands at 6M. In comparison, MTRI has a market cap of 4.6M. Regarding current trading prices, HGYN is priced at $0.08, while MTRI trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HGYN currently has a P/E ratio of N/A, whereas MTRI's P/E ratio is 12.50. In terms of profitability, HGYN's ROE is -0.43%, compared to MTRI's ROE of N/A. Regarding short-term risk, HGYN is less volatile compared to MTRI. This indicates potentially lower risk in terms of short-term price fluctuations for HGYN.Check MTRI's competition here
HGYN vs PLPL Comparison May 2026
HGYN plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HGYN stands at 6M. In comparison, PLPL has a market cap of 4.5M. Regarding current trading prices, HGYN is priced at $0.08, while PLPL trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HGYN currently has a P/E ratio of N/A, whereas PLPL's P/E ratio is -0.01. In terms of profitability, HGYN's ROE is -0.43%, compared to PLPL's ROE of +0.00%. Regarding short-term risk, HGYN is more volatile compared to PLPL. This indicates potentially higher risk in terms of short-term price fluctuations for HGYN.Check PLPL's competition here